Correlation between immune-related adverse events and therapeutic effects of nivolumab in patients with malignant pleural mesothelioma

BACKGROUND: Nivolumab is used for the treatment of malignant pleural mesothelioma (MPM). However, immune-related adverse events (irAEs) occur in patients treated with nivolumab. Several studies have reported the correlation between irAEs and therapeutic effects of immune checkpoint inhibitor, but no...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoneda, Hiroto, Nokihara, Hiroshi, Mitsuhashi, Atsushi, Ozaki, Ryohiko, Yabuki, Yohei, Ogino, Hirokazu, Otsuka, Kenji, Nishioka, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591924/
https://www.ncbi.nlm.nih.gov/pubmed/34781910
http://dx.doi.org/10.1186/s12890-021-01746-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591924/
https://www.ncbi.nlm.nih.gov/pubmed/34781910
http://dx.doi.org/10.1186/s12890-021-01746-6

Ejemplares similares